In addition, as knocking down of BIRC3 resulted in a 30% decrease in cell proliferation, a 20% increase in apoptosis and delayed migration of SGC-7901 cells, it has been postulated that BIRC3 is a potential target for GC therapy [61]. This evidence concerns the gene BIRC3 and gastric cancer.